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Original ArticleNoggin depletion in adipocytes promotes obesity
in miceAna M. Blázquez-Medela 1, Medet Jumabay 1, Prashant Rajbhandari 5, Tamer Sallam 1, Yina Guo 1, Jiayi Yao 1,
Laurent Vergnes 5, Karen Reue 5, Li Zhang 1, Yucheng Yao 1, Alan M. Fogelman 3, Peter Tontonoz 4,
Aldons J. Lusis 1,5,6, Xiuju Wu 1,**, Kristina I. Boström 1,2,*,7ABSTRACT
Objective: Obesity has increased to pandemic levels and enhanced understanding of adipose regulation is required for new treatment strategies.
Although bone morphogenetic proteins (BMPs) influence adipogenesis, the effect of BMP antagonists such as Noggin is largely unknown. The aim
of the study was to define the role of Noggin, an extracellular BMP inhibitor, in adipogenesis.
Methods: We generated adipose-derived progenitor cells and a mouse model with adipocyte-specific Noggin deletion using the Adiponectin Cre
transgenic mouse, and determined the adipose phenotype of Noggin-deficiency.
Results: Our studies showed that Noggin is expressed in progenitor cells but declines in adipocytes, possibly allowing for lipid accumulation.
Correspondingly, adipocyte-specific Noggin deletion in vivo promoted age-related obesity in both genders with no change in food intake. Although
the loss of Noggin caused white adipose tissue hypertrophy, and whitening and impaired function in brown adipose tissue in both genders, there
were clear gender differences with the females being most affected. The females had suppressed expression of brown adipose markers and
thermogenic genes including peroxisome proliferator activated receptor gamma coactivator 1 alpha (PGC1alpha) and uncoupling protein 1 (UCP1)
as well as genes associated with adipogenesis and lipid metabolism. The males, on the other hand, had early changes in a few BAT markers and
thermogenic genes, but the main changes were in the genes associated with adipogenesis and lipid metabolism. Further characterization
revealed that both genders had reductions in VO2, VCO2, and RER, whereas females also had reduced heat production. Noggin was also reduced
in diet-induced obesity in inbred mice consistent with the obesity phenotype of the Noggin-deficient mice.
Conclusions: BMP signaling regulates female and male adipogenesis through different metabolic pathways. Modulation of adipose tissue
metabolism by select BMP antagonists may be a strategy for long-term regulation of age-related weight gain and obesity.
 2019 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords Noggin; Bone morphogenetic protein; Adipocyte; Adipogenesis; Obesity1. INTRODUCTION
Approximately two-thirds of the adult American population suffer from
overweight or obesity, which is closely linked to adipose-tissue
dysfunction and inflammation, type 2 diabetes, insulin resistance
and cardiovascular disease [1,2]. There are at least two types of ad-
ipose tissue in mammals [3e5]: white adipose tissue (WAT), which
has a central role in energy storage, hormone production and organ
protection, and brown adipose tissue (BAT), which is highly vascu-
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a mitigating effect on cardiovascular disease [6]. Recent studies have
shown that WAT can transition into BAT and vice versa, phenomena
that are usually referred to as “browning” and “whitening”, respec-
tively [7,8]. The adipocytes that are responsible for “browning” have
been labeled either “beige” or “brite” (brown-in-white) adipocytes
[9,10]. The classical brown precursor cells derive from the dermato-
myotome that express Engrailed and Myf5, whereas the beige/brite
adipocytes emerge in WAT, which derive from pluripotent mesodermal
stem cells [4,5]. In addition, both types of adipocytes have been traced095, USA 2Molecular Biology Institute, UCLA, USA 3Department of Medicine, David
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Abbreviations
Adipoq adiponectin
aP2 adipocyte protein 2
ASC adipose stromal cell
ALK activin receptor-like kinase
Cdh5 cadherin 5, VE-cadherin
BAT brown adipose tissue
BMI body mass index
BMP bone morphogenetic protein
CD cluster of differentiation
Cebpa CCAAT/enhancer-binding protein alpha
Cox cytochrome c oxidase
Cpt1a/Cpt1b carnitine palmitoyltransferase 1A/1B
CT computed tomography
CV2 crossveinless 2
DAPI 40,6-diamidino-2-phenylindole
DFAT cells dedifferentiated fat cells
Dio2 iodothyronine deiodinase 2
DMEM Dulbecco’s modified Eagle’s Medium
EE energy expenditure
Elovl ELOVL fatty acid elongase
ERa estrogen receptor alpha
Fabp4 fatty acid-binding protein
FACS fluorescence-activated cell sorting
FASN fatty acid synthase
18F-FDG 18F-fludeoxyglucose
FITC fluorescein isothiocyanate
F, Fl flox
GAPDH glyceraldehyde-3-phosphate dehydrogenase
HF/HS high-fat/high-sucrose
HOMA-IR insulin resistance index
HMDP hybrid mouse diversity panel
HSL hormone-sensitive lipase
ICAM intercellular adhesion molecule
ID inhibitor of DNA binding
IL interleukin
MGP matrix Gla protein
Nog noggin
OCR oxygen consumption rate
Oct octamer-binding transcription factor
p phosphorylated, phospho
PBS phosphate-buffered saline
PE phycoerythrin
PET positron emission tomography
PGC1a peroxisome proliferator activated receptor gamma coactivator
1 alpha
PRDM16 PR domain-containing 16
RER respiratory exchange ratio
SCD1 stearoyl-CoA desaturase-1
Slc27a2 solute carrier family 27 member2
SMAD transcription factors with homology to the Caenorhabditis
elegans SMA and Drosophila MAD family of genes
TCF21 transcription factor 21
TGFb transforming growth factor b
UCP1 uncoupling protein 1
VCAM-1 vascular cell adhesion protein 1
VO2 oxygen consumption
WAT white adipose tissue
WB washing buffer
Zic1 Zic family member 1from progenitor cells in perivascular areas, and even the vascular
endothelium [11,12].
The bone morphogenetic proteins (BMPs) are part of the transforming
growth factor b (TGFb) superfamily, and regulate development and
tissue differentiation through their influences on cell proliferation,
lineage and migration [13,14]. The best known functions of the
members of the BMP subfamily are related to bone and cartilage
formation, but many BMPs are also involved in the development and
pathophysiology of other organs, including the cardiovascular system
[15,16], nervous system [17], kidneys [18], lungs [19] and adipose
tissue [5,20]. During development, gradients of BMPs and BMP in-
hibitors are established and help specify cell differentiation in tissue
formation [21]. Analogously, niches with ‘hot spots’ of high local BMP
concentrations may exist in various tissues. For example, perivascular
niches have been described where endothelial responses to circulating
factors are transmitted to adipogenic progenitor cells [22].
BMP2 and BMP4 have been reported to stimulate white adipogenesis,
whereas BMP4 and BMP7 are essential in the induction of brown
adipogenesis [20,23e26]. Roles for BMP4 and BMP7 have also been
described in the browning and whitening of adipose tissue [23,24,27].
BMP8b may have a role in modulating thermogenesis in BAT [28] and
adrenergic-induced remodeling of the adipose neuro-vascular network
[29]. It has also been described that the absence of the activin
receptor-like kinase (ALK)3 (also referred to as BMPR1A) either in cells
from the Myf5þ lineage (brown preadipocytes) or in all adipocytesMOLECULAR METABOLISM 25 (2019) 50e63  2019 The Authors. Published by Elsevier GmbH. This is an open ac
www.molecularmetabolism.comleads to a deficiency in brown fat [30]. Interestingly, BMP9, which is
highly expressed in liver and circulates in plasma, has been shown to
regulate enzymes involved in glucose homeostasis and to be a strong
inducer of brown adipogenesis [31].
The BMP activity is frequently modulated by extracellular inhibitors
such as matrix Gla protein (MGP), Noggin, and Gremlin [32e34].
However, these are secreted proteins with abilities to bind BMP2, 4,
and 7 [32e35] and could therefore affect adipogenesis. However, the
understanding of their roles in adipose tissue remains in large part
unclear and contradictory. MGP is highly expressed in differentiating
human preadipocytes [36], and is higher in omental than subcutane-
ous adipose tissue [37]. Noggin, however, was reported to induce
adipogenesis in mesenchymal stem cells from mouse bone marrow,
and to circulate at higher levels in human subjects with body mass
index (BMI) > 27 [38], whereas other investigators found that Noggin
reduced cell differentiation in human adipose stromal cells [39].
Gremlin has been reported to inhibit adipocyte differentiation [40,41],
cause preadipocyte resistance to BMP4 and impair regulation of beige
and brown adipogenesis [42].
Here we address whether the BMP inhibitor Noggin has the ability of
modulating adipose tissue and obesity in vivo through adipocyte-
specific gene deletion of the Noggin gene in mouse. Our findings
provide evidence that Noggin is a regulator of adipose tissue, and
Noggin deficiency promotes age-related whitening of BAT and white
adipose hypertrophy associated with obesity.cess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 51
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2.1. Mice
Nogginflox/flox (Nogfl/fl) (Nog tm1.1Rmh/J, stock #016117) [43], Adi-
ponectin (Adipoq)Cre (B6; FVB-Tg(Adipoq-cre)1Evdr/J, stock #010803)
[44], and VE-cadherin (Cadherin5, Cdh5)Cre (B6.FVB-Tg(Cdh5-cre)
7Mlia/J, stock #006137) [45] were obtained from the Jackson Labo-
ratory. All mice were on C57BL/6J background. Genotypes were
confirmed by PCR [46], and experiments were performed with gen-
erations F4-F6. Littermates were used as wild type controls. All mice
were fed a standard chow diet (Teklad Rodent Diet 8604, Envigo,
Placentia, CA). The use of animals and all experimental procedures
were reviewed and approved by the University of California Los
Angeles (UCLA) Chancellor’s Animal Research Committee and con-
ducted in accordance with the animal care guideline set by UCLA. The
investigation conformed to the National Research Council, Guide for the
Care and Use of Laboratory Animals, Eighth Edition (Washington, DC:
The National Academies Press, 2011).
2.2. Preparation of adipose tissue-derived progenitor cells
Dedifferentiated fat (DFAT) cells and adipose stromal cells (ASCs)
were prepared from 2 g of subcutaneous WAT or interscapular BAT
collected from wild type C57BL/6J mice aged 8e10 weeks, as
previously described [47e49]. The DFAT cells were used after
passage of the initial preparation from adipocytes, between passages
1e3, and the experiments where performed in adipogenic medium
from the StemPro Adipogenesis Differentiation Kit (Gibco/Ther-
mofisher Scientific, Waltham, MA). Recombinant human BMP4 and
Noggin, and anti-Noggin antibodies (Cat. No. AF719) were from R&D
Systems (Minneapolis, MN). The ASCs were sorted by FACS as
outlined below.
2.3. Body fat determination
Whole body fat, fluids and lean muscle mass of isoflurane-
anesthetized mice were determined biweekly using a Bruker Optics
Minispec NMR analyzer (Billerica, MA) in accordance with the manu-
facturer’s recommendations.
2.4. Indirect calorimetry and respiratory measurements
Energy expenditure, food intake, and ambulatory activity were deter-
mined by using the Oxymax/CLAMS Comprehensive Lab Animal
Monitoring System (Columbus Instruments, Columbus, OH). Respira-
tory measurements were made in 20 min intervals after an initial 12 h
acclimation period. Energy expenditure (EE) was calculated from ox-
ygen consumption (VO2) and respiratory exchange ratio (RER) using the
Lusk equation, EE in cal/min ¼ (3.815 þ 1.232  RER)  VO2 in ml/
min [50]. Statistical significance for EE measurements was determined
by using 2-way-ANOVA.
2.5. Glucose tolerance test
Mice aged one year were fasted for 6 h prior to the beginning of the
test. Baseline measurements of blood glucose were obtained (Optium
EZ kit from Abbott, Lake Bluff, IL), and the mice were injected with
2 mg glucose (Millipore Sigma, Billerica, MA) per gram of body weight.
Additional blood glucose measurements were taken at 15, 30, 60, and
90 min after the injection.
2.6. Immunofluorescence
Tissues were collected at 2 months and 1 year of age. Subcutaneous
fat pads were collected in the inguinal and axillary regions (the latter
corresponding to the anterior subcutaneous fat pad in [51]). Visceral fat52 MOLECULAR METABOLISM 25 (2019) 50e63  2019 The Authors. Published by Elsevier GmbH. Tpads were collected in the gonadal and omental regions, and brown fat
was collected in the interscapular region.
Tissue sections were prepared and stained as previously described
[52]. Briefly, 4 mm-sections were fixed in 4% paraformaldehyde and
processed as described. For immunohistochemistry and immunoflu-
orescence, sections were permeabilized with 0.5% Triton X-100 for
10 min, followed by 3 washes with wash buffer (WB, phosphate-
buffered saline (PBS) containing 0.1% Tween-20). Non-specific anti-
body binding sites were blocked by incubating the sections for 30 min
in blocking buffer (1% BSA, 2% goat serum and 0.5% Triton X-100 in
PBS). Primary antibodies were diluted in antibody buffer (PBS con-
taining 1% BSA, 0.5% Triton X-100), and sections were incubated for
overnight at 4 C, followed by several washes in WB. Alexa Fluor 488-
conjugated (green fluorescence) or Alexa Fluor 594-conjugated (red
fluorescence) secondary goat anti-chicken or goat anti-rabbit anti-
bodies (Molecular Probes, Eugene, OR) or Streptavidin (Vector Labo-
ratories, Burlingame, CA, USA) were applied to the sections and
incubated for 60 min at room temperature. After several washes in WB
and a brief equilibration of the sections in PBS, the nuclei were stained
with 40,6-diamidino-2-phenylindole (DAPI, Sigma-Aldrich, St. Louis,
MO). A DAPI stock solution was diluted to 300 nM in PBS, and 300 ml of
the diluted solution was added to the sections, making certain that they
were completely covered. The sections were incubated for 1e5 min
and rinsed several times in PBS. Staining without primary antibodies
served as controls. Slides without primary antibodies were used as
negative controls. Images were acquired with an inverted Nikon
Eclipse TieS microscope (Nikon Corporation, Tokyo, Japan). We used
biotinylated isolectin B4 (Vector Laboratories, Burlingame, CA), and
specific antibodies for Perilipin (Cat. No. 9349S, Cell Signaling, Dan-
vers, MA), Noggin (Cat. No. AF719, R&D Systems, Minneapolis, MN),
and beta-catenin (Cat. No. ab16051, Abcam, Cambridge, MA). The
preparations were mounted with Prolong Gold Antifade Mountant
(Thermo Fisher Scientific, Canoga Park, CA). Image analysis was
performed on sections stained with anti-perilipin antibodies using
Wolfram Mathematica 10 (Wolfram Research, Champaign, IL). Only
cells with clear cell boundaries were included in the analysis
(Supplemental Fig. 1).
2.7. RNA analysis
Total RNA was isolated from tissues or cultured cells using the miR-
Neasy Mini kit (Qiagen, Redwood City, CA) according to the manu-
facturer’s instructions. cDNA was obtained using the High Capacity
cDNA Reverse Transcription kit from Applied Biosystems (Foster City,
CA). Relative quantitative PCR was performed on a 7500 Fast Real-
Time PCR System using TaqMan Universal PCR Master Mix (both
from Applied Biosystems). Primers and probes for mouse genes BMP2,
BMP4, BMP7, BMP8b, Gremlin, matrix Gla protein (MGP), cross-
veinless 2 (CV2), Noggin, cluster of differentiation (CD)36, CD31, CD68,
Adiponectin (Adipoq), Uncoupling Protein 1 (UCP1), PR domain-
containing 16 (PRDM16), octamer-binding transcription factor (Oct)3/
4, transcription factor 21 (TCF21), Cidea, peroxisome proliferator
activated receptor gamma coactivator 1 alpha (Pgc1a), cytochrome c
oxidase polypeptide 7A1 (Cox7a1), cytochrome c oxidase subunit 8B
(Cox8b), iodothyronine deiodinase 2 (Dio2), Zic family member 1 (Zic1),
CCAAT/enhancer-binding protein alpha (Cebpa), ELOVL fatty acid
elongase 3 (Elovl3), Elovl6, solute carrier family 27 member2
(Slc27a2), carnitine palmitoyltransferase 1A (Cpt1a), Cpt1b, interleukin
6 (IL-6), intercellular adhesion molecule 1 (ICAM-1), and vascular cell
adhesion protein 1 (VCAM-1) were obtained from Applied Biosystems
as part of Taqman Gene Expression Assays. Cycle conditions were:
one cycle at 50 C for 2 min, followed by one cycle at 95 C for 10 min,his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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followed by 40 cycles at 95 C for 15 s and 60 C for 1 min. Threshold
cycles of specific cDNAs were compared to the housekeeping gene
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or 18S ribo-
somal RNA (18S rRNA) as previously described [53].
2.8. Immunoblotting
Immunoblotting was performed as previously described [46,54]. Equal
amounts of tissue protein were used. Blots were incubated with
specific antibodies to UCP1 (1:1,000 dilution; Cat. No. ab10983, Cell
Signaling Technology) or phospho-SMAD1/5 (Ser463/465) (41D10)
(1:1,000 dilution; Cell Signaling Technology, Cat. No. #9516), total
SMAD (1:1,000 dilution; Santa Cruz Biotechnology, sc-7153), beta-
actin (1:2,000 dilution; Sigma-Aldrich, Cat. No. A2228), hormone-
sensitive lipase (HSL) (1:1,000 dilution; Cell Signaling Technology,
Cat. No. 4107), phospho-HSL (Ser660) (1:1,000 dilution; Cell Signaling
Technology, Cat. No. 4126), fatty acid synthase (FASN) (1:1,000
dilution; Cell Signaling Technology, Cat. No. #3180), and stearoyl-CoA
desaturase-1 (SCD1) (0.2 mg/ml; Santa Cruz Biotechnology, Cat. No.
sc-14719).
2.9. Fluorescence-activated cell sorting (FACS)
FACS was performed as previously described [55], and used to sort
freshly isolated ASCs into CD34CD31, CD34þCD31,
CD34þCD31þ, and CD34CD31þ cell fractions using fluorescein
isothiocyanate (FITC)-conjugated antibodies against CD34 (1:200; Cat.
No. 11-0341-85, eBioscience, San Diego, CA) or phycoerythrin (PE)-
conjugated antibodies against mouse CD31 (1:200; Cat. No. 561073,
BD Biosciences Pharmingen). Nonspecific fluorochrome- and isotype-
matched IgGs (BD Pharmingen) served as controls. Flow cytometer
gates were set using unstained cells and the isotype-matched controls.
Cells were gated by forward scatter (FSC) versus side scatter (SSC) to
eliminate debris. A region was established to define positive PE/AF-
488 fluorescence using a PE/AF-488-conjugated isotype-specific
control. The number of cells stained positive for a given marker was
determined by the percentage of cells present within a gate, which was
established such that fewer than 2% of positive events represented
nonspecific binding by the PE/AF-488-conjugated isotype-specific
control. Minimums of 10,000 events were counted for each analysis.
All FACS analyses were performed using a BD LSR II flow cytometer
(BD Biosciences). FACS files were exported and analyzed using BD
Cellquest software v.3.3.
2.10. Oil Red O staining
For Oil Red O staining, cells that were seeded at 70% confluency and
treated as indicated in the text. The staining was performed using
standard methods. To stain isolated adipocytes, floating adipocytes
were collected in a new tube and AdipoRed (Lonza Biosciences,
Walkersville, MD) diluted1:50 was added together with DAPI diluted
1:200 and incubated at room temperature for 20 min with soft shaking.
The adipocytes were washed once more with PBS before mounting the
preparation.
2.11. Brown fat activity
The experiments were performed in sub-thermoneutral conditions
(20 C) and after cold treatment at 4 C as previously described [56].
Animals of two months and one year of age received one injection of
approximately 70 m Cu of 18F-Fludeoxyglucose (FDG) via the tail vein. A
1-h interval for uptake was allowed between probe administration and
micro-positron emission tomography (micro-PET)/micro-computed
tomography (micro-CT) scanning. Image acquisition and reconstruc-
tion were performed as previously described [57]. Briefly, mice wereMOLECULAR METABOLISM 25 (2019) 50e63  2019 The Authors. Published by Elsevier GmbH. This is an open ac
www.molecularmetabolism.complaced in a dedicated imaging chamber designed for use for the CT and
both PET systems. Data were acquired by using a Genisys 8 PET/CT
(Sofie Biosciences, Culver City, CA) for 10 min and a MicroCAT II small-
animal CT scanner (Siemens ImTek Inc. Knoxville, TN) for 8 min. Micro-
PET images were reconstructed by using statistical maximum a pos-
teriori probability algorithms (MAP) into multiple frames. Micro-CT
Images were reconstructed using filtered back-projection without
scatter or attenuation correction. We chose a ramp filter with a cutoff
frequency of 0.5 and a zoom of 5 to give a voxel size of 0.379 mm3.
PET and CT Images were analyzed using Amide Software (version
1.16).
2.12. Respiratory rate measurement
The oxygen consumption rate (OCR) in fat pads was measured with an
XF24 Analyzer (Seahorse Bioscience) as described [58]. Briefly, freshly
isolated brown and white adipose tissues were minced and rinsed in
cold PBS, placed in a Seahorse Islet Capture Microplate (3e5 mg per
well), and incubated with 625 ml of unbuffered Dulbecco’s Modified
Eagle Medium (DMEM) (containing 2.5 mM glucose). OCR was
measured before and after the injection of 200 mM etomoxir. The
etomoxir-sensitive respiration represents the beta-oxidation. Experi-
ments were triplicated; differences were tested by two-way ANOVA.
2.13. The hybrid mouse diversity panel (HMDP)
HMDP data was analyzed from 95 inbred mouse strains fed a standard
chow diet and 110 inbred strains fed a high-fat/high sucrose diet for 8
weeks as previously described [59e61]. Gene expression compari-
sons were analyzed in 75 overlapping strains from two HMDP studies
using global gene expression in epididymal adipose tissue in male
mice. The correlations of gene expression and phenotypic data were
calculated with the biweight midcorrelation using R package WGCNA.
2.14. Statistical analysis
Data were analyzed for statistical significance by two-way ANOVA with
post hoc Tukey’s analysis or multiple t test with HolmeSidak
correction for multiple comparisons using GraphPad Prism 6.0
software (GraphPad Software, San Diego, CA). Unpaired student’s t
test was used for single variable comparison between two groups.
Data are presented as mean  SEM. p-values less than 0.05 were
considered statistically significant. All experiments were repeated a
minimum of three times.
3. RESULTS
3.1. Noggin as a potential regulator of adipose tissue
To examine the potential role of BMP inhibition in adipogenic differ-
entiation, we compared the expression of BMP4 and BMP7, which are
known to be associated with adipogenesis with that of Noggin, a well-
established BMP inhibitor. Noggin was expressed in both WAT and
BAT, as determined by qPCR (Figure 1A), and was detected by
immunofluorescence in proximity of both adipocytes and CD31þ
capillaries (Figure 1B). We then compared Noggin expression to that of
BMP4, BMP7 and MGP, another BMP inhibitor, in the adipocytes and
the different ASCs fractions. Both adipocytes and ASCs expressed
Noggin. The ASCs fraction from subcutaneous WAT was sorted by
FACS using antibodies to the vascular markers CD34 and CD31. White
adipocytes and four ASCs fractions (82.1% CD34CD31, 3.4%
CD34þCD31, 2.9% CD34þCD31þ, and 11.4% CD34CD31þ
cells) were analyzed by qPCR. The results revealed that the expression
of BMP4, BMP7 and MGP was highest in the CD34þCD31 cells
(Figure 1C), suggesting that the BMPs from these cells might trigger orcess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 53
Figure 1: Noggin expression in tissue, and effect of Noggin on adipose-derived progenitor cells (DFAT cells) in vitro. (A) Noggin expression in white and brown fat depots compared to the axillary depot. (B) Immunofluorescence for Noggin (green)
in subcutaneous WAT; co-stained with the endothelial marker CD31 (red). DAPI (blue) was used to visualize nuclei (bars, 100 mm). (C) Expression of Noggin, BMP4, BMP7 and MGP in white ASCs fractions obtained by FACS using antibodies to
CD31 and CD34, compared to white adipocytes, as determined by qPCR. (D, E) DFAT cells derived from WAT were treated for 12 days with control (vehicle or non-specific IgG), BMP4, Noggin and anti-Noggin antibodies in adipogenic medium.
(D) The cells were stained by Oil Red O, and (E) expression of adipogenic markers and the stem cell marker Oct3/4 was determined by qPCR. *<0.05, **<0.01, ***<0.001.
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modulate adipogenic differentiation. The expression of Noggin, on the
other hand, was similar in all the ASCs fractions and significantly
higher than in the adipocytes (Figure 1C). Therefore, we hypothesized
that decreases in Noggin allowed for lipid accumulation, a late char-
acteristic of adipogenic differentiation.
To assess the effect of Noggin on lipid accumulation in adipogenic
precursor cells in vitro, we cultured DFAT cells in adipogenic medium
and treated the cells with control (non-specific IgG), BMP4 (50 ng/ml),
Noggin (100 ng/ml) or neutralizing anti-Noggin antibodies (300 ng/ml)
for 12 days. The medium was changed on days 5 and 9. The results
showed that BMP4 and the anti-Noggin antibodies promoted lipid
accumulation compared to control, as shown by Oil Red O staining,
whereas Noggin suppressed the lipid accumulation (Figure 1D).
Expression of the adipogenic markers adiponectin, Tcf21 and CD36
were consistent with the Oil Red O staining, whereas the beige/brown
markers did not change significantly (Figure 1E). Interestingly, the
stem cell marker Oct3/4 was enhanced in the Noggin-treated cells
(Figure 1E), supporting that Noggin counteracts differentiation in these
cells. Similar results were seen when treating 3T3-L1 cells, an alter-
native cell line (data not shown).
3.2. Noggin-deficiency promotes obesity and enlargement of lipid
droplets in female and male mice
To determine the role of Noggin in adipose tissue, we generated mice
with adipocyte-specific Noggin deficiency by crossbreeding Nogfl/fl and
AdipoqCre mice to obtain Nogfl/fl;AdipoqCre mice. Noggin expression in
the different fat pads from these mice was significantly reduced when
compared to their Nogfl/fl littermates, as determined by qPCR and
visualized by immunofluorescence (Supplemental Figs. 2A and B). As
would be expected, low levels of Noggin continued to co-localize with
isolectin B4, a capillary marker, consistent with the adipocyte-specific
Noggin deletion. We also generated Nogfl/fl;Cdh5Cre control mice with
endothelial cell-specific Noggin deficiency for comparison.
Female and male Nogfl/fl;AdipoqCre mice were allowed an ad libitum
chow diet for up to one year, and body weight, body composition, and
size of fat pads were monitored. The body weight and percent fat
gradually increased and started to show significant differences at 9
and 6e9 months, respectively, compared to Nogfl/fl mice, as assessed
by NMR (Supplemental Fig. 3). The differences were highly significant
in both genders of the Nogfl/fl;AdipoqCre mice after one year (Figure 3A)
when the females had nearly doubled their body weight. The muscle
mass did not differ at any time point (Supplemental Fig. 3, Figure 2A).
Similarly, the weight of the axillary, inguinal and gonadal fat pads, as
compared to body weight, was significantly increased in females after
2 months and in both genders after one year (Supplemental Fig. 4A,
Figure 2B). No differences in body weight, body composition or BAT
were detected in female or male Nogfl/fl;Cdh5Cre mice with the
endothelial-specific Noggin loss, as compared to the Nogfl/fl mice
(Supplemental Figs. 5A and B). Together, the results suggested that
loss of Noggin in adipocytes promotes weight gain and an increase in
adipose tissue with age in both genders.
Noggin provides antagonism to several BMPs, including BMP2, 4, and
7 [32] and likely BMP8b based on its close alignment with BMP7 [13].
To determine the effect of Noggin deficiency on white adipocytes,
sections from the different fat pads were stained with anti-perilipin
antibodies and the area of the sectioned adipocytes was determined
using immunofluorescence and image analysis. Subcutaneous (axillary
and inguinal) and visceral (gonadal and omental) fat pads were
examined in females and males. At 2 months, only the subcutaneous
adipocytes in male mice were larger in the Noggin-deficient animals
(Supplemental Fig. 4B). After one year, however, adipocytes inMOLECULAR METABOLISM 25 (2019) 50e63  2019 The Authors. Published by Elsevier GmbH. This is an open ac
www.molecularmetabolism.comsubcutaneous fat pads as well as in the omental fat pads were
significantly larger in the Noggin-deficient mice of both genders
(Figure 2C). The gonadal fat pads also showed a significant enlarge-
ment in males, but not in females (Figure 2C). Again, no significant
difference was detected in the Nogfl/fl;Cdh5Cre mice with endothelial
Noggin loss, as compared to the Nogfl/fl mice at one year of age
(Supplemental Fig. 5C). Our results suggest that the reduced Noggin
levels allowed for a potential rebalancing of the overall BMP activity
that enhanced lipid accumulation with age. However, this effect was
influenced by fat location and gender.
3.3. Noggin-deficiency affects BAT structure and functionality
Since Noggin is known to modulate BMP4 as well as BMP7 [32e
34,62], the latter essential in brown adipogenesis, we expected that
brown adipogenesis would also be affected. We examined BAT at 2
months and one year in the Nogfl/fl;AdipoqCre mice and compared to
control Nogfl/fl mice by H&E staining and anti-perilipin immunofluo-
rescence. This revealed that brown adipocytes in Noggin-deficient
females and males had larger lipid droplets than the respective con-
trol animals at both time points (Figure 3A), suggesting that lack of
Noggin promotes lipid accumulation also in brown adipocytes. It also
suggested that the BAT function was altered as a result of the reduced
Noggin expression. Therefore, we assessed the BAT function at 20 C
by PET at 2 months and one year of age. At 2 months, the 18F-FDG
uptake in BAT was less in females than in males in both types of mice,
and both genders of the Nogfl/fl;AdipoqCre mice exhibited lower 18F-
FDG uptake than the Nogfl/fl control mice (Figure 3B). At one year of
age, the decrease in BAT activity was more pronounced in females
than in males, but the control mice continued to have higher 18F-FDG
uptake than the Nogfl/fl;AdipoqCre mice of the same gender (Figure 3B).
The alteration in thermogenesis was confirmed by cold exposure ex-
periments at 4 C, which clearly showed less 18F-FDG uptake in the
BAT of both female and male Nogfl/fl;AdipoqCre mice at 2 months and
one year of age (Figure 3C). Thus, the results suggested that the
reduction in Noggin affected the BAT, and that part of the obesity in the
Nogfl/fl;AdipoqCre mice might be due to the impaired BAT function.
3.4. Noggin deficiency affects metabolism and adipogenic
differentiation
To investigate possible causes of the increase in adipose tissue, we
analyzed metabolic differences between Nogfl/fl;AdipoqCre and Nogfl/fl
control mice at 2 months of age using metabolic cages. This was prior
to detectable differences in weight and body fat. The results showed
that the Nogfl/fl;AdipoqCre mice of both genders exhibited significant
decreases in VO2, VCO2, and RER (Figure 4A, B). The females also
exhibited a decrease in heat production, which was not observed in the
males (Figure 4A, B). However, there was no significant difference in
the cumulative food intake between the Nogfl/fl;AdipoqCre and Nogfl/fl
control mice of the same gender (Figure 4C, D). The food intake was
measured from the time the mice were placed in the metabolic cages
until the metabolic data collection was complete. In addition, no dif-
ferences were detected in locomotor or ambulatory activity. On the
other hand, there were significant increases in plasma levels of tri-
glycerides and total cholesterol in the Nogfl/fl;AdipoqCre mice
(Supplemental Fig. 6A). We also noted an increase in glucose and an
increasing trend in insulin levels in the Nogfl/fl;AdipoqCre mice
(Supplemental Fig. 6A), suggesting that the mice were developing
glucose intolerance. Indeed, both genders showed evidence of glucose
intolerance at 2 months of age (Figure 5D), and both genders devel-
oped histological signs of fatty liver at one year of age (Supplemental
Fig. 7B).cess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 55
Figure 2: Adipocyte-specific deletion of Noggin in mice promotes obesity. Female and male mice with adipocyte-specific deletion of Noggin (Nogfl/fl;AdipoqCre or KO) and control mice (Nogfl/fl or F/F) aged one year were analyzed in regards to (A)
body weight and percent fat and muscle (bars, 10 mm), (B) fat pad size from the axillary, inguinal and gonadal locations (bars, 10 mm), and (C) adipocyte size as determined by cell area after immunofluorescence for Perilipin (green). Sections
were co-stained for CD31 (red) and DAPI (blue) was used to visualize nuclei (bars, 100 mm).
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Figure 3: Adipocyte-specific deletion of Noggin impairs BAT function in mice. BAT from female and male mice with adipocyte-specific deletion of Noggin (Nogfl/fl;AdipoqCre or KO)
and control mice (Nogfl/fl or F/F) aged 2 months and one year was examined. (A) Sections of BAT were stained by H&E staining (left panels) and immunofluorescence for Perilipin
(green) (right panels). Sections were co-stained for CD31 (red) and DAPI (blue) was used to visualize nuclei (bars, 100 mm). (B) 18F-FDG uptake in BAT at 20 C was visualized by
PET (left panels) and subsequently quantified (right panels) (bars, 10 mm). (C) Quantification of 18F-FDG uptake in BAT after cold exposure at 4 C.To further investigate BAT function, we first confirmed that the Noggin
deletion enhanced the canonical SMAD activation in the BAT as ex-
pected. Indeed, the activation (phosphorylation) of SMAD1/5, media-
tors of BMP signaling, was increased in both female and male mice at
2 and 6 months of age, as determined by immunoblotting. Total SMAD,
which is shown for comparison, did not change (Figure 5C, top two
lanes).MOLECULAR METABOLISM 25 (2019) 50e63  2019 The Authors. Published by Elsevier GmbH. This is an open ac
www.molecularmetabolism.comWe then investigated the expression by qPCR of BAT markers and
thermogenic genes (PGC1a, UCP1, Cidea, Cox7a1, Cox8b, PRDM16,
Dio2, and Zic1 [63]), and adipogenic and lipid metabolism regulatory
genes (Cebpa, Elovl3, Elovl6, CD36, Slc27a2, Cpt1a, Cpt1b, and adi-
ponectin). The expression was examined in BAT from mice aged 2
months and one year. The results showed that all the BAT markers and
thermogenic genes decreased or showed a decreasing trend in femalecess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 57
Figure 4: Adipocyte-specific deletion of Noggin in mice affects heat production, respiratory exchange ratio and oxygen consumption. Female and male mice with adipocyte-
specific deletion of Noggin (Nogfl/fl;AdipoqCre or KO) and control mice (Nogfl/fl or F/F) aged 2 months were examined in metabolic cages. (A, B) VO2, VCO2, RER and heat pro-
duction for female (A) and male (B) mice (n ¼ 4e6). (C) Food intake in female and male mice (n ¼ 4e6). (D) Glucose tolerance test in female and male mice (n ¼ 6e7). p-values
are indicated in the respective panels.
Original ArticleNogfl/fl;AdipoqCre mice (Figure 5A), whereas only Dio2 and Zic1 showed
an early decrease (at 2 months) in male Nogfl/fl;AdipoqCre mice
(Figure 5A). The decrease in UCP1 in female Noggin-deficient mice
was confirmed by immunoblotting (Figure 5C). Furthermore, the adi-
pogenic and lipid metabolism regulatory genes also decreased in the
female Nogfl/fl;AdipoqCre mice, especially after one year (Figure 5B),
whereas an early increase of Cebpa, Elovl3 and Elovl6 (at 2 months)
was observed in the male Nogfl/fl;AdipoqCre mice (Figure 5B).
In addition, we investigated the expression by immunoblotting of the
lipogenic genes FASN and SCD1 and the lipolytic gene HSL. Both FASN
and SCD1 as well as HSL and phosphorylated (p)-HSL decreased in the
female Nogfl/fl;AdipoqCre mice (Figure 5C). Interestingly, FASN and
SCD1 showed a late induction (at 6 months) without a change in HSL or
p-HSL in the male Noggin-deficient males.
Thus, there were clear gender differences with the females being the
most affected gender. The females showed a suppression in BAT
markers and genes associated with thermogenesis, adipogenesis and
lipolysis, whereas the males showed early changes in a few of the BAT
markers and thermogenic genes, and then a late induction of the
lipogenic genes FASN and SCD1. Together, it suggests that the BMP
signaling regulates female and male adipogenesis through different
metabolic pathways.
Finally we analyzed the oxygen consumption rate (OCR) in BAT from
female and male Nogfl/fl;AdipoqCre and Nogfl/fl control mice at 2 months
of age, before major weight gains in the Noggin-deficient mice. The
analysis showed no difference in the basal OCR in females, whereas it
was decreased in the males (Figure 5D). After addition of etomoxir, an58 MOLECULAR METABOLISM 25 (2019) 50e63  2019 The Authors. Published by Elsevier GmbH. Tinhibitor of Cpt1a, an additional reduction in OCR was seen in the Nogfl/
fl;AdipoqCre mice, as compared to the Nogfl/fl control mice (Figure 5D),
suggesting an impaired potential for beta-oxidation in Noggin-deficient
BAT.
Expression of inflammatory markers, including the macrophage
marker CD68, IL-6, and the adhesion molecules ICAM-1 and VCAM-1
were enhanced in BAT at one year of age in females but not in males
(Supplemental Fig. 7). No change was detected in the expression of the
endothelial marker CD31 (data not shown).
The differential effect of Noggin deletion on the transcriptional land-
scape may explain the greater obesity in the Nogfl/fl;AdipoqCre mice
females, as compared to the males. This suggests that changes in
BMP signaling have gender-specific effects, and that the females are
more responsive to Noggin depletion and the corresponding increase in
BMP activity, especially at an early stage, which is suggested by the
strong p-SMAD1/5 activation at 2 months of age (Figure 5C).
3.5. Expression of BMPs and BMP inhibitors in the HMDP
The HMDP is a collection of approximately 100 well-characterized
inbred strains of mice that display a substantial diversity of meta-
bolic phenotypes relevant to human obesity. We explored two studies
in the HMDP database established by Lusis et al. [59e61,64]. First, we
found that certain BMPs have relationships with obesity phenotypes,
adipose expression of BMP7 in particular correlates negatively with
body weight, percent fat, and insulin resistance index (HOMA-IR)
(Figure 6A). We further discovered that expression of several BMP
signaling components changed significantly in adipose tissue inhis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 5: Adipocyte-specific deletion of Noggin affects expression of markers for adipogenic lineage, mitochondria and b-oxidation. Adipose tissues were collected from female
and male mice with adipocyte-specific deletion of Noggin (Nogfl/fl;AdipoqCre or KO) and control mice (Nogfl/fl or F/F) aged 2 months and one year. (A, B) Gene expression was
determined by qPCR for (A) BAT markers and thermogenic genes, and (B) lipogenesis and lipid metabolism regulatory genes. n ¼ 3; *<0.05, **<0.01, ***<0.001. (C) Gene
expression was determined by immunoblotting for phosphorylated (p)-SMAD1/5 as compared to total SMAD, UCP1, p-HSL and HSL, FASN, and SCD1. Beta-actin is shown as a
control. (D) Oxygen consumption rate (OCR) in BAT from female and male Nogfl/fl;AdipoqCre and Nogfl/fl control mice in BAT at 2 months of age; basal OCR in females (top) and after
addition of etomoxir (bottom). *<0.05, **<0.01, ***<0.001, ****<0.0001.response to a high-fat/high-sucrose (HF/HS) diet as compared to
chow-fed mice by microarray expression. Noggin and BMP7 both
decreased and BMP2 increased, whereas BMP4 did not change
significantly, although downstream BMP activity might intensify due to
the lack of Noggin. In addition, the BMP type 1 receptors ALK2 and
ALK3 were induced by the HF/HS diet, whereas the ALK1 and ALK6
receptors were suppressed, allowing for another level of BMP regu-
lation (Figure 6B). Overall, the HMDP results supported that BMP
modulation is important in adipose regulation.
4. DISCUSSION
Our results demonstrate that Noggin modulates BMP signaling in ad-
ipose tissue in a way that may have long-term protective actions
against obesity. The results suggest that Noggin provides such pro-
tection by limiting lipid accumulation in individual adipocytes; loss of
Noggin causes a “whitening” of BAT and hypertrophy of WAT through
regulation of the genes for BAT differentiation and thermogenesis as
well as for lipid metabolism regulatory genes. Furthermore, the effect
is influenced by age and gender, and was especially pronounced in
females. The impaired BAT function was detected early and preceded
significant changes in the WAT.MOLECULAR METABOLISM 25 (2019) 50e63  2019 The Authors. Published by Elsevier GmbH. This is an open ac
www.molecularmetabolism.comBMP signaling is important in both morphogenesis and cell differen-
tiation, and constellations of BMPs and BMP antagonists often act in
time- and space-dependent manners during development [13,14]. The
relationship between the BMPs and their antagonists can be compli-
cated since most of the antagonists inhibit multiple BMPs each
[32,33,35], and some are induced by the BMP signaling as part of
feedback regulation [65]. Therefore, the removal of an inhibitor can
sway the entire system rather than make a discrete change in the
activity of one BMP. The BMP signaling was increased in the Noggin-
deficient adipose tissue, as observed by increased the p-SMAD1/5
phosphorylation. However, we cannot with certainty link this change in
SMAD activation to a specific BMP since Noggin antagonizes several
BMPs including BMP4 and BMP7 [34], and possibly BMP8b due to its
similarity to BMP7.
The results showed that Noggin expression was relatively stable in the
sub-fractions of the ASCs, whereas that of BMP4, BMP7 and MGP was
strongest in the CD34-positive cells. It is possible that Noggin is part of
a temporal regulation, and functions as a barrier to activation of certain
BMPs until the cells are ready for lipid accumulation. The in vitro re-
sults supported a negative correlation between Noggin and lipid
accumulation and adipogenic differentiation, an overall opposite action
to that of BMP4, at least in vitro. A decrease in Noggin might alsocess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 59
Figure 6: Adipose expression of BMP signaling components respond to high fat/high sucrose feeding in mice in the HMDP database. (A) Relationship between adipose expression
of BMP7 and obesity phenotypes. (B) Expression of BMP signaling components responds to HF/HS diet compared to chow, as determined by microarray expression.
Original Articlemodulate the fat distribution by counteracting BMP2, which stimulates
white adipogenesis and is more expressed in visceral than in subcu-
taneous fat depots [20]. A loss of Noggin would be less likely, however,
to be due to enhanced BMP8b activity since this has been reported to
increases brown adipose tissue thermogenesis [28].60 MOLECULAR METABOLISM 25 (2019) 50e63  2019 The Authors. Published by Elsevier GmbH. TWhen comparing our results to the HMDP database, Noggin expression
is decreased in diet-induced obesity in mice from the HMDP, which
would be consistent with the obesity phenotype seen in Noggin-
deficient mice. BMP7 decreased in concert with Noggin, whereas
BMP2 increased, suggesting that increased BMP2 activity may behis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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important in handling the incoming lipids. The declining BMP7 would
be expected to further enhance the whitening, resulting in an asso-
ciation between low BMP7 levels and increased body weight, body fat,
HOMA-IR and mesenteric fat.
Overall, a change in the inhibitor levels may have unexpected effects
depending on the underlying BMP balance. Protein characteristics,
cellular location, binding to the extracellular matrix, timing and location
of expression, and varying affinities for various BMPs or BMP receptors
are all aspects that can influence the role of an inhibitor. Indeed, the
variety of inhibitors will make them, as a group, the perfect mediators
of numerous BMP functions. For example, Noggin is a soluble protein
[66] that diffuses in the tissue and contributes to tissue gradients of
BMP activity. Gremlin, on the other hand, is able to form large com-
plexes with BMP [67], while MGP is a poorly soluble protein that might
immobilize BMPs in the matrix [68]. Both Gremlin and MGP are
secreted by preadipocytes [36,42], but it is unclear how they differ in
their BMP inhibitory function during differentiation compared to
Noggin.
Our results are consistent with previous reports from Modica et al. [27]
that showed that overexpression of BMP4 in brown tissue after intra-
brown tissue administration of Bmp4-containing adenoviral vectors
induced a shift to white-like phenotype in the brown adipocytes. In
contrast, Qian et al. [23] demonstrated that BMP4 overexpression
regulated by the fatty acid-binding protein (Fabp4)/adipocyte Protein 2
(aP2) promoter caused induction of oxidative genes and smaller lipid
droplets. The use of the aP2-promoter has been reported to result in
ectopic expression of BMP4 in multiple cells including macrophages
and endothelial cells [69], which might explain the different results,
especially when considering that adipocytes have been traced from
endothelial cells [11].
It has been reported that the maximum size of adipocytes is around
1.0 mg of lipid per cell [70]. Here it appears that it can be exceeded in
Noggin-deficient adipocytes in certain locations. Assuming that the
calculated areas represent cross-sections of spherical adipocytes, the
estimated size of the largest adipocytes would be in the range of 5e
6 mg of lipid, i.e. 5e6-fold larger than the largest adipocyte in obese
patients [70].
In our studies, the BMP signaling is affected by gender, and activated
p-SMAD1/5 is higher in females at an early age. This effect may derive
from gender differences in the upstream regulation of the BMP genes
or in the downstream target genes, such as the inhibitor of DNA
binding (ID) transcription factors. Indeed, Qian et al. [71] reported that
reciprocal interactions between BMP4 and estrogen/ERa signaling
could promote obesity and insulin resistance in aging female mice.
These interactions could be directly targeted by Noggin through its
interaction with BMP4. The findings by Grefhorst et al. [72] might also
be applicable in our case. They reported that estrogen increases
BMP8b expression in BAT, which might add to the effect on the BAT
and the thermogenesis in the female mice. The male mice showed
little difference in the thermogenic genes, but did show evidence of
enhanced lipogenesis ultimately resulting in a similar phenotype.
On the transcriptional level, the ID1-4 transcription factors have been
implicated in the regulation of adipogenic differentiation and devel-
opment [73]. These are frequently targeted by BMP signaling. Inter-
estingly, overexpression of ID1 in the adipose tissue results in age-
associated and diet-induced obesity in mice, which has similarities
to the Noggin-deficient phenotype, whereas lack of ID1 enhances the
expression of UCP1 and genes associated with beige adipocytes in
response to cold exposure [74]. Thus, the ID factors are likely to be
important in mediating the BMP effects in adipose tissue. Altogether,MOLECULAR METABOLISM 25 (2019) 50e63  2019 The Authors. Published by Elsevier GmbH. This is an open ac
www.molecularmetabolism.comthe differences that arise from gender-specific differences in the
Noggin-deficient mice will require further investigations.
5. CONCLUSIONS
Noggin declines in adipose progenitor cells during adipogenesis in vitro
allowing for lipid accumulation. In a similar way, adipocyte-specific
Noggin depletion in mice promotes age-related obesity with white
adipose tissue hypertrophy in subcutaneous and omental fat pads, and
whitening, reduced brown adipose function and diminished expression
of PGC1alpha and UCP1. The obesity is age-related, independent of
food intake, and occurs in both genders, but with reductions in heat
production and expression of mitochondria and beta-oxidation markers
restricted to female mice. Thus, the BMP antagonists may be essential
for long-term regulation of obesity.
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